Clinical Trial Detail

NCT ID NCT02630420
Title Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Yale University
Indications

head and neck squamous cell carcinoma

colorectal cancer

Therapies

Cetuximab + Savolitinib

Age Groups: adult

Additional content available in CKB BOOST